Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Exploristics - Innovative Analysis Solutions for Data Exploration, Pharmacogenetics, Biomarkers and Exploratory Statistical Analysis News

Exploristics - Innovative Analysis Solutions for Data Exploration, Pharmacogenetics, Biomarkers and Exploratory Statistical Analysis

Optimising Drug Supply and Patient Recruitment Exploristics, the innovative analytics group, now offers a suite of state-of-the-art predictive modelling tools for optimising drug supply and patient recruitment in clinical trials.
View press release
Title: Exploristics Ltd publishes Pharmacogenetics paper in Drug Discovery Today Exploristics, the innovative data analysis group, published a paper describing the practices and opportunities for study design and data analysis in Pharmacogenetics (PGx).
View press release
Exploristics receives R&D grant to develop Personalised Medicine Simulation Tool Exploristics, the innovative data analysis and modelling company, is pleased to announce that is has received a grant from Invest NI to develop a simulation tool to optimise the design of research programs for Personalised Medicine.
View press release
Anaxsys Receives CE Mark for their Respiratory Rate Monitor with the Support of Exploristics Exploristics, the innovative analysis group, is pleased to announce that Anaxsys Limited have received the CE Mark for their respiratory rate monitor, respiR8, from the British Standards Institute (BSI).
View press release
Exploristics Can Discover Hidden Gems in Your Clinical Development Portfolio Exploristics, the innovative data analysis company, is pleased to announce a new service that helps Pharmaceutical and Biotechnology companies identify and exploit new opportunities within their clinical development portfolios.
View press release
Exploristics Support the Design and Validation of Clinical Rating Scales and QoL Data Exploristics, the innovative data analysis company, is pleased to announce the release of a new service that helps clinical researchers from across the healthcare sector to design and validate rating scales and Quality of Life instruments as well as composite endpoints.
View press release